These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 6337271)

  • 1. Newly licensed hepatitis B vaccine. Known safety and unknown risks.
    Gerety RJ; Tabor E
    JAMA; 1983 Feb; 249(6):745-6. PubMed ID: 6337271
    [No Abstract]   [Full Text] [Related]  

  • 2. AIDS transmission: what about the hepatitis B vaccine?
    Macek C
    JAMA; 1983 Feb; 249(6):685-6. PubMed ID: 6823017
    [No Abstract]   [Full Text] [Related]  

  • 3. The use of hepatitis B virus vaccine.
    Chin J
    N Engl J Med; 1982 Sep; 307(11):678-9. PubMed ID: 6810171
    [No Abstract]   [Full Text] [Related]  

  • 4. Hepatitis B vaccine: demonstration of efficacy in a controlled clinical trial in a high-risk population in the United States.
    Szmuness W; Stevens CE; Harley EJ; Zang EA; Oleszko WR; William DC; Sadovsky R; Morrison JM; Kellner A
    N Engl J Med; 1980 Oct; 303(15):833-41. PubMed ID: 6997738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Looks like smooth sailing for experimental hepatitis B vaccine.
    Check WA
    JAMA; 1981 Nov; 246(19):2111-2. PubMed ID: 7026816
    [No Abstract]   [Full Text] [Related]  

  • 6. The newly licensed hepatitis B vaccine. Characteristics and indications for use.
    Krugman S
    JAMA; 1982 Apr; 247(14):2012-5. PubMed ID: 7038174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Update: hepatitis B vaccine "the FDA approved the new vaccine on November 17, 1981".
    Miller PJ
    Infect Control; 1982; 3(1):76-7. PubMed ID: 6915903
    [No Abstract]   [Full Text] [Related]  

  • 8. Indications for use of hepatitis B vaccine, based on cost-effectiveness analysis.
    Mulley AG; Silverstein MD; Dienstag JL
    N Engl J Med; 1982 Sep; 307(11):644-52. PubMed ID: 6810170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Immunoprophylaxis and immunotherapy of viral hepatitis].
    Furuta S
    Nihon Rinsho; 1981 Apr; 39(4):1784-90. PubMed ID: 6171653
    [No Abstract]   [Full Text] [Related]  

  • 10. [Hepatitis B vaccine: results of the Belgian clinical trials with 150 volunteers].
    Donéa-Debroise B; François-Gérard C; Sondag-Thull D; André A
    Rev Med Liege; 1982 Apr; 37(8):261-7. PubMed ID: 7048477
    [No Abstract]   [Full Text] [Related]  

  • 11. Hepatitis B vaccination of hemophiliacs.
    Desmyter J; Colaert J; Verstraete M; Vermylen J
    Scand J Infect Dis Suppl; 1983; 38():42-5. PubMed ID: 6580726
    [No Abstract]   [Full Text] [Related]  

  • 12. Large-scale efficacy trials of hepatitis B vaccines in the USA: baseline data and protocols.
    Szmuness W
    J Med Virol; 1979; 4(4):327-40. PubMed ID: 541683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccination of children with malignant diseases with alum-absorbed hepatitis B vaccine--Immunogenicity studies.
    Arnold W; Baumann W
    Scand J Infect Dis Suppl; 1983; 38():33-6. PubMed ID: 6580724
    [No Abstract]   [Full Text] [Related]  

  • 14. Should homosexuals be vaccinated against hepatitis B virus?
    Br Med J (Clin Res Ed); 1983 Jun; 286(6382):1978. PubMed ID: 6407669
    [No Abstract]   [Full Text] [Related]  

  • 15. Hepatitis B virus vaccine.
    Williams A
    Nurse Pract; 1983 Oct; 8(9):30-2. PubMed ID: 6633987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prevention of hepatitis B with vaccine. Report of the centers for disease control multi-center efficacy trial among homosexual men.
    Francis DP; Hadler SC; Thompson SE; Maynard JE; Ostrow DG; Altman N; Braff EH; O'Malley P; Hawkins D; Judson FN; Penley K; Nylund T; Christie G; Meyers F; Moore JN; Gardner A; Doto IL; Miller JH; Reynolds GH; Murphy BL; Schable CA; Clark BT; Curran JW; Redeker AG
    Ann Intern Med; 1982 Sep; 97(3):362-6. PubMed ID: 6810736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High prevalence of anti-hepatitis B core antigen in hepatitis B virus-vaccinated Chinese blood donors suggests insufficient protection but little threat to the blood supply.
    Zheng X; Ye X; Du P; Zeng J; Zhu W; Yang B; Li C; Allain JP
    Transfusion; 2015 Apr; 55(4):890-7. PubMed ID: 25363504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunoprophylaxis of hepatitis B. 2. Active immunization: vaccine production, vaccine safety, side effects].
    Zoulek G; Jilg W; Deinhardt F
    Dtsch Med Wochenschr; 1983 Aug; 108(31-32):1175-7. PubMed ID: 6872870
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical trial of vaccine for type B hepatitis to begin next month.
    Gunby P
    JAMA; 1979 Mar; 241(10):979-80. PubMed ID: 581678
    [No Abstract]   [Full Text] [Related]  

  • 20. [Viral hepatitis B vaccine].
    Leone G; Melino G
    Clin Ter; 1983 Mar; 104(6):483-93. PubMed ID: 6851450
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.